Abstract Details

Title Mesenchymal Stem Cells Engineered to Overexpress Brain-Derived Neurotrophic Factor as a Proposed Therapeutic for Huntington’s Disease

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 007

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Vicki L. Wheelock, MD (UC Davis Department of Neurology) PRESENTER	Dr. Wheelock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Wheelock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. Dr. Wheelock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME Continuing Medical ��ɫ��.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Gerhard Bauer	No disclosure on file
Alexandra O. Duffy, MD, FAAN (UC Davis Health)	Dr. Duffy has nothing to disclose.
	No disclosure on file
Jan Nolta, PhD (University of California Davis)	No disclosure on file

��ɫ����